Skip to main content

About your Search

20131101
20131130
Search Results 0 to 0 of about 1
it isn't doing for patients with chronic diseases like ms. i'm steve usdin. welcome to "biocentury this week." >> your trusted source for biotechnology information andable sis -- and analysis, "biocentury this week." >>> more than 2 million people around the world are affected by multiple sclerosis, a debilitating autoimmune disease. ms is caused by the destruction of milen, a fatty protective coating that surrounds nerve fibers. without it signals can't move through nerves causing loss of muscle control and other symptoms. drugs slow and prevent milen destruction slowing progression and helping patients manage their disease but even though patients have more therapies than ever, nothing repairs milen so they can't reverse the loss of muscle function. since 2004 the milen repair function has been conducting and coordinating research for a goal of getting drugs to patients by 2016. cutting in half the time it usually takes to go from a concept to a new drug. if it works, the milen repair foundation will not only change the lives of ms patients, also create a model that could
Search Results 0 to 0 of about 1